Alpa Laboratories Limited
Simbolis: ALPA.BO
BSE
90.5
INRRinkos kaina šiandien
10.3959
P/E santykis
-0.9674
PEG koeficientas
1.90B
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Alpa Laboratories Limited (ALPA-BO) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 808.4 | 702.7 | 424.9 | |||||||||||||||
balance-sheet.row.short-term-investments | 0 | 720.3 | 687 | 406.9 | |||||||||||||||
balance-sheet.row.net-receivables | 0 | 501.4 | 430.8 | 381.4 | |||||||||||||||
balance-sheet.row.inventory | 0 | 126.4 | 154.6 | 165.6 | |||||||||||||||
balance-sheet.row.other-current-assets | 0 | 81.6 | 72.7 | 107.8 | |||||||||||||||
balance-sheet.row.total-current-assets | 0 | 1491.2 | 1380.1 | 1210.9 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 69.6 | 92.2 | 87.3 | |||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0.8 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0.8 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.long-term-investments | 0 | 96.5 | 61.5 | 104.9 | |||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 9.3 | 0 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 14.5 | 8.3 | 0 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 181.4 | 172.3 | 192.8 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 0 | 1672.7 | 1552.4 | 1403.7 | |||||||||||||||
balance-sheet.row.account-payables | 0 | 150.6 | 149.2 | 247.3 | |||||||||||||||
balance-sheet.row.short-term-debt | 0 | 15.3 | 37.2 | 1.8 | |||||||||||||||
balance-sheet.row.tax-payables | 0 | 22.8 | 25.7 | 2.9 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 7.8 | 21.2 | 0.1 | |||||||||||||||
Deferred Revenue Non Current | 0 | 0 | -25.7 | -2.2 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 0 | 73.4 | 67.4 | 38.8 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 7.8 | 21.2 | 0.1 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-liab | 0 | 326.9 | 335.1 | 327.3 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 0 | 210.4 | 210.4 | 210.4 | |||||||||||||||
balance-sheet.row.retained-earnings | 0 | 585.8 | 457.3 | 316.4 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 760 | 760 | 760 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -210.4 | -210.4 | -210.4 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1345.8 | 1217.3 | 1076.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1672.7 | 1552.4 | 1403.7 | |||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-equity | 0 | 1345.8 | 1217.3 | 1076.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||
Total Investments | 0 | 77.7 | 74.7 | 101.5 | |||||||||||||||
balance-sheet.row.total-debt | 0 | 23 | 58.5 | 1.9 | |||||||||||||||
balance-sheet.row.net-debt | 0 | -65.1 | 42.7 | -16.1 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 156.8 | 195.6 | 107.9 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 13.3 | 16.6 | 12.3 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -8 | 14.5 | -103.4 | |||||||||||||||
cash-flows.row.account-receivables | 0 | -66.4 | -0.3 | -185 | |||||||||||||||
cash-flows.row.inventory | 0 | 28.2 | 11 | -40.1 | |||||||||||||||
cash-flows.row.account-payables | 0 | 19.8 | -78.9 | 127.2 | |||||||||||||||
cash-flows.row.other-working-capital | 0 | 10.3 | 82.8 | -5.5 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -73 | -127.3 | -33.8 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -11.3 | -21.9 | -32.2 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | -5 | 42.3 | 3.7 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -0.3 | -191.8 | 7.9 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 12.3 | 15.4 | 79.1 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | 25.5 | -0.1 | 0.1 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 21.3 | -156.1 | 58.6 | |||||||||||||||
cash-flows.row.debt-repayment | 0 | -35.4 | -21.2 | -1.8 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-financing-activites | 0 | -2.5 | 75.6 | 3.7 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -37.9 | 54.4 | 1.9 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | -0.1 | |||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 72.4 | -2.3 | 43.4 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 88.1 | 15.8 | 105.1 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 15.8 | 18 | 61.7 | |||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 89 | 99.4 | -17 | |||||||||||||||
cash-flows.row.capital-expenditure | 0 | -11.3 | -21.9 | -32.2 | |||||||||||||||
cash-flows.row.free-cash-flow | 0 | 77.8 | 77.5 | -49.2 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 924.1 | 1105.1 | 964.1 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 615 | 760.9 | 647.6 | |||||||||||||||
income-statement-row.row.gross-profit | 0 | 309.1 | 344.3 | 316.6 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 0 | 28.8 | 1.5 | 0.5 | |||||||||||||||
income-statement-row.row.operating-expenses | 0 | 235.5 | 248.8 | 219.4 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 850.5 | 1009.7 | 867 | |||||||||||||||
income-statement-row.row.interest-income | 0 | 10.4 | 14.6 | 6.5 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.8 | 1.1 | 0.3 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 81 | 101.1 | 41.7 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 28.8 | 1.5 | 0.5 | |||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 81 | 101.1 | 41.7 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.8 | 1.1 | 0.3 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 13.3 | 16.6 | 12.3 | |||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 0 | 67.5 | 79.6 | 69 | |||||||||||||||
income-statement-row.row.income-before-tax | 0 | 158.9 | 195.6 | 107.9 | |||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 33.1 | 54.7 | 35.4 | |||||||||||||||
income-statement-row.row.net-income | 0 | 125.8 | 140.9 | 72.5 |
Dažnai užduodami klausimai
Kas yra Alpa Laboratories Limited (ALPA.BO) bendras turtas?
Alpa Laboratories Limited (ALPA.BO) bendras turtas yra 1672699000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.350.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 7.032.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.157.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.135.
Kas yra Alpa Laboratories Limited (ALPA.BO) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 125828000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 23040000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 235520000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.